vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $35.2M, roughly 1.7× NATIONAL RESEARCH CORP). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -12.5%, a 17.7% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -4.6%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $6.1M). Over the past eight quarters, CBAK Energy Technology, Inc.'s revenue compounded faster (-0.0% CAGR vs -0.2%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

CBAT vs NRC — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.7× larger
CBAT
$58.8M
$35.2M
NRC
Growing faster (revenue YoY)
CBAT
CBAT
+136.4% gap
CBAT
131.8%
-4.6%
NRC
Higher net margin
NRC
NRC
17.7% more per $
NRC
5.1%
-12.5%
CBAT
More free cash flow
CBAT
CBAT
$10.0M more FCF
CBAT
$16.1M
$6.1M
NRC
Faster 2-yr revenue CAGR
CBAT
CBAT
Annualised
CBAT
-0.0%
-0.2%
NRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBAT
CBAT
NRC
NRC
Revenue
$58.8M
$35.2M
Net Profit
$-7.4M
$1.8M
Gross Margin
7.3%
Operating Margin
-13.6%
13.3%
Net Margin
-12.5%
5.1%
Revenue YoY
131.8%
-4.6%
Net Profit YoY
-63.6%
-72.6%
EPS (diluted)
$-0.08
$49.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
NRC
NRC
Q4 25
$58.8M
$35.2M
Q3 25
$60.9M
$34.6M
Q2 25
$40.5M
$34.0M
Q1 25
$34.9M
$33.6M
Q4 24
$25.4M
$36.9M
Q3 24
$44.6M
$35.8M
Q2 24
$47.8M
$35.0M
Q1 24
$58.8M
$35.3M
Net Profit
CBAT
CBAT
NRC
NRC
Q4 25
$-7.4M
$1.8M
Q3 25
$2.7M
$4.1M
Q2 25
$-3.1M
$-106.0K
Q1 25
$-1.6M
$5.8M
Q4 24
$-4.5M
$6.6M
Q3 24
$17.6K
$5.7M
Q2 24
$6.4M
$6.2M
Q1 24
$9.8M
$6.4M
Gross Margin
CBAT
CBAT
NRC
NRC
Q4 25
7.3%
Q3 25
8.0%
Q2 25
11.0%
Q1 25
13.7%
Q4 24
13.1%
Q3 24
15.6%
Q2 24
26.6%
Q1 24
31.9%
Operating Margin
CBAT
CBAT
NRC
NRC
Q4 25
-13.6%
13.3%
Q3 25
-6.6%
22.4%
Q2 25
-8.7%
4.7%
Q1 25
-8.2%
25.6%
Q4 24
-26.0%
26.0%
Q3 24
-1.9%
22.3%
Q2 24
12.4%
25.3%
Q1 24
17.4%
24.8%
Net Margin
CBAT
CBAT
NRC
NRC
Q4 25
-12.5%
5.1%
Q3 25
4.4%
11.9%
Q2 25
-7.6%
-0.3%
Q1 25
-4.5%
17.2%
Q4 24
-17.8%
17.8%
Q3 24
0.0%
15.9%
Q2 24
13.5%
17.6%
Q1 24
16.7%
18.0%
EPS (diluted)
CBAT
CBAT
NRC
NRC
Q4 25
$-0.08
$49.58
Q3 25
$0.03
$0.18
Q2 25
$-0.03
$-0.01
Q1 25
$-0.02
$0.25
Q4 24
$-0.05
$0.27
Q3 24
$0.00
$0.24
Q2 24
$0.07
$0.26
Q1 24
$0.11
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
NRC
NRC
Cash + ST InvestmentsLiquidity on hand
$8.3M
$4.1M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$112.7M
$14.0M
Total Assets
$426.2M
$134.9M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
NRC
NRC
Q4 25
$8.3M
$4.1M
Q3 25
$10.5M
$2.2M
Q2 25
$45.7M
$5.3M
Q1 25
$9.6M
$2.5M
Q4 24
$11.0M
$4.2M
Q3 24
$24.2M
$3.5M
Q2 24
$44.1M
$485.0K
Q1 24
$23.8M
$1.7M
Total Debt
CBAT
CBAT
NRC
NRC
Q4 25
$4.1M
Q3 25
$4.8M
Q2 25
$4.9M
Q1 25
$4.1M
Q4 24
Q3 24
$48.7M
Q2 24
$33.3M
Q1 24
$35.2M
Stockholders' Equity
CBAT
CBAT
NRC
NRC
Q4 25
$112.7M
$14.0M
Q3 25
$121.4M
$14.3M
Q2 25
$118.2M
$21.3M
Q1 25
$120.8M
$29.7M
Q4 24
$121.7M
$31.3M
Q3 24
$131.2M
$34.6M
Q2 24
$126.6M
$40.2M
Q1 24
$120.9M
$36.9M
Total Assets
CBAT
CBAT
NRC
NRC
Q4 25
$426.2M
$134.9M
Q3 25
$363.9M
$135.7M
Q2 25
$333.1M
$141.4M
Q1 25
$311.5M
$135.2M
Q4 24
$302.2M
$132.5M
Q3 24
$293.5M
$131.8M
Q2 24
$279.6M
$119.1M
Q1 24
$286.5M
$120.9M
Debt / Equity
CBAT
CBAT
NRC
NRC
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
1.41×
Q2 24
0.83×
Q1 24
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
NRC
NRC
Operating Cash FlowLast quarter
$29.8M
$7.2M
Free Cash FlowOCF − Capex
$16.1M
$6.1M
FCF MarginFCF / Revenue
27.3%
17.2%
Capex IntensityCapex / Revenue
23.4%
3.2%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$15.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
NRC
NRC
Q4 25
$29.8M
$7.2M
Q3 25
$14.6M
$13.8M
Q2 25
$13.8M
$-1.1M
Q1 25
$-9.6M
$6.6M
Q4 24
$9.6M
$6.4M
Q3 24
$19.7M
$9.4M
Q2 24
$2.9M
$6.8M
Q1 24
$7.4M
$12.0M
Free Cash Flow
CBAT
CBAT
NRC
NRC
Q4 25
$16.1M
$6.1M
Q3 25
$6.0M
$10.2M
Q2 25
$4.1M
$-4.1M
Q1 25
$-22.3M
$3.7M
Q4 24
$3.9M
$1.9M
Q3 24
$16.5M
$7.8M
Q2 24
$2.5M
$1.5M
Q1 24
$-454.0K
$7.9M
FCF Margin
CBAT
CBAT
NRC
NRC
Q4 25
27.3%
17.2%
Q3 25
9.9%
29.4%
Q2 25
10.2%
-12.2%
Q1 25
-63.9%
10.9%
Q4 24
15.5%
5.2%
Q3 24
37.1%
21.8%
Q2 24
5.2%
4.3%
Q1 24
-0.8%
22.4%
Capex Intensity
CBAT
CBAT
NRC
NRC
Q4 25
23.4%
3.2%
Q3 25
14.1%
10.4%
Q2 25
23.8%
8.8%
Q1 25
36.3%
8.9%
Q4 24
22.5%
12.0%
Q3 24
7.0%
4.5%
Q2 24
0.9%
15.0%
Q1 24
13.4%
11.7%
Cash Conversion
CBAT
CBAT
NRC
NRC
Q4 25
3.99×
Q3 25
5.51×
3.34×
Q2 25
Q1 25
1.15×
Q4 24
0.97×
Q3 24
1115.72×
1.66×
Q2 24
0.46×
1.10×
Q1 24
0.76×
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

NRC
NRC

Segment breakdown not available.

Related Comparisons